Boberg KM - Search Results

1

FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.

Wannhoff A, Hov JR, Folseraas T, Rupp C, Friedrich K, Anmarkrud JA, Weiss KH, Sauer P, Schirmacher P, Boberg KM, Stremmel W, Karlsen TH, Gotthardt DN. Wannhoff A, et al. Among authors: boberg km. J Hepatol. 2013 Dec;59(6):1278-84. doi: 10.1016/j.jhep.2013.08.005. Epub 2013 Aug 16. J Hepatol. 2013. PMID: 23958938

2

Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development.

Boberg KM, Schrumpf E, Bergquist A, Broomé U, Pares A, Remotti H, Schjölberg A, Spurkland A, Clausen OP. Boberg KM, et al. J Hepatol. 2000 Mar;32(3):374-80. doi: 10.1016/s0168-8278(00)80386-4. J Hepatol. 2000. PMID: 10735605

3

Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitis.

Fleming KA, Boberg KM, Glaumann H, Bergquist A, Smith D, Clausen OP. Fleming KA, et al. Among authors: boberg km. J Hepatol. 2001 Mar;34(3):360-5. doi: 10.1016/s0168-8278(00)00034-9. J Hepatol. 2001. PMID: 11322195

4

Endoscopic treatment for primary sclerosing cholangitis?

Schrumpf E, Boberg KM. Schrumpf E, et al. Among authors: boberg km. J Hepatol. 2002 Feb;36(2):278-9. doi: 10.1016/s0168-8278(01)00292-6. J Hepatol. 2002. PMID: 11830341 Review. No abstract available.

5

Cholangiocarcinoma in situ in primary sclerosing cholangitis: diagnosis by brush cytology and treatment by liver transplantation.

Boberg KM, Jebsen P, Clausen OP, Aabakken L, Brekke I, Schrumpf E. Boberg KM, et al. J Hepatol. 2003 Sep;39(3):453. doi: 10.1016/s0168-8278(03)00326-x. J Hepatol. 2003. PMID: 12927935 No abstract available.

6

Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis.

Bowlus CL, Karlsen TH, Broomé U, Thorsby E, Vatn M, Schrumpf E, Lie BA, Boberg KM. Bowlus CL, et al. Among authors: boberg km. J Hepatol. 2006 Nov;45(5):704-10. doi: 10.1016/j.jhep.2006.03.012. Epub 2006 Apr 25. J Hepatol. 2006. PMID: 16750586

7

The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients.

Melum E, Karlsen TH, Broomé U, Thorsby E, Schrumpf E, Boberg KM, Lie BA. Melum E, et al. Among authors: boberg km. Tissue Antigens. 2006 Jul;68(1):78-81. doi: 10.1111/j.1399-0039.2006.00604.x. Tissue Antigens. 2006. PMID: 16774544

8

Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.

Boberg KM, Jebsen P, Clausen OP, Foss A, Aabakken L, Schrumpf E. Boberg KM, et al. J Hepatol. 2006 Oct;45(4):568-74. doi: 10.1016/j.jhep.2006.05.010. Epub 2006 Jun 21. J Hepatol. 2006. PMID: 16879890 Clinical Trial.

9

Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.

Karlsen TH, Hampe J, Wiencke K, Schrumpf E, Thorsby E, Lie BA, Broomé U, Schreiber S, Boberg KM. Karlsen TH, et al. Among authors: boberg km. Am J Gastroenterol. 2007 Jan;102(1):115-21. doi: 10.1111/j.1572-0241.2006.00928.x. Epub 2006 Nov 13. Am J Gastroenterol. 2007. PMID: 17100974

10

Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes.

Wiencke K, Karlsen TH, Boberg KM, Thorsby E, Schrumpf E, Lie BA, Spurkland A. Wiencke K, et al. Among authors: boberg km. Tissue Antigens. 2007 Feb;69(2):161-9. doi: 10.1111/j.1399-0039.2006.00738.x. Tissue Antigens. 2007. PMID: 17257319

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters